The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 26, 2017
Filed:
Jun. 01, 2015
Applicant:
Theranos, Inc., Palo Alto, CA (US);
Inventors:
Timothy Michael Kemp, Palo Alto, CA (US);
Chris Todd, Palo Alto, CA (US);
Ron Oral, Palo Alto, CA (US);
Shulin Zeng, Palo Alto, CA (US);
John Howard, Palo Alto, CA (US);
Jeff Fenton, Palo Alto, CA (US);
Assignee:
Theranos, Inc., Palo Alto, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/543 (2006.01); G01N 21/76 (2006.01); B01L 3/00 (2006.01); G01N 33/53 (2006.01); A61B 5/15 (2006.01); A61B 5/145 (2006.01); A61B 5/00 (2006.01); G01N 33/50 (2006.01); A61B 5/155 (2006.01); G06F 19/00 (2011.01); A61B 5/151 (2006.01); A61B 5/157 (2006.01); A61B 5/1495 (2006.01);
U.S. Cl.
CPC ...
G01N 21/76 (2013.01); A61B 5/1411 (2013.01); A61B 5/1427 (2013.01); A61B 5/14532 (2013.01); A61B 5/157 (2013.01); A61B 5/15142 (2013.01); A61B 5/412 (2013.01); A61B 5/417 (2013.01); B01L 3/50273 (2013.01); G01N 33/50 (2013.01); G01N 33/53 (2013.01); G01N 33/5302 (2013.01); G01N 33/54386 (2013.01); G06F 19/3406 (2013.01); A61B 5/1495 (2013.01); A61B 5/14546 (2013.01); A61B 5/150022 (2013.01); A61B 5/150099 (2013.01); A61B 5/150251 (2013.01); A61B 5/150854 (2013.01); B01L 2300/021 (2013.01); B01L 2300/023 (2013.01); B01L 2300/044 (2013.01); B01L 2300/0636 (2013.01); B01L 2300/087 (2013.01); B01L 2300/0816 (2013.01); B01L 2300/0867 (2013.01); B01L 2300/0877 (2013.01); B01L 2300/0883 (2013.01); B01L 2300/0887 (2013.01); G01N 2500/00 (2013.01); Y10T 436/10 (2015.01); Y10T 436/11 (2015.01); Y10T 436/115831 (2015.01); Y10T 436/12 (2015.01); Y10T 436/143333 (2015.01);
Abstract
This invention is in the field of medical devices. Specifically, the present invention provides fluidic systems having a plurality of reaction sites surrounded by optical barriers to reduce the amount of optical cross-talk between signals detected from various reaction sites. The invention also provides a method of manufacturing fluidic systems and methods of using the systems.